###### Article summary

Article focus
=============

-   Up to 40% of infants and children experience sleep problems, which are associated with poorer health and academic outcomes.

-   These problems are treatable but, until their avoidable health cost burden is made clear, it is unlikely that these effective programmes will be made more widely available.

Key messages
============

-   Sleep problems in infants and children account for substantial primary healthcare costs to the public purse.

-   Persistent problems are associated with the greatest costs.

-   The study suggests that population healthcare expenditures could be reduced if sleep interventions can be provided cost-effectively.

Strengths and limitations of the study
======================================

-   Healthcare costs reported using administrative data used by the Australian government to fund the healthcare system

-   Generalisability and precision of findings through a nationally-representative sampling frame, large sample size and high retention rate.

-   Despite the marked increases associated with sleep problems, this study cannot infer causality because data does not specifically separate the costs of seeking and receiving help for the sleep problem itself from the costs of seeking help for other conditions.

Introduction {#s1}
============

Up to 40% of parents report that their infants and young children experience sleep problems,[@R1; @R2; @R3] which are in turn associated with increased child inattention, poorer social and emotional skills and poorer learning and memory formation.[@R4; @R5; @R6; @R7; @R8; @R9] They are also of great concern to parents,[@R10] and are associated with disruptions to employment and increased mental health problems.[@R11; @R12; @R13] Most sleep problems in this age group are behavioural in nature, for example, difficulty settling to sleep and frequent night waking. Fortunately effective treatments are available[@R14; @R15; @R16] and these can actually save on costs.[@R15] [@R17]

Additional healthcare costs associated with sleep problems could reflect the increased use of household and community resources invested in addressing sleep problems, to their comorbidities, or to any underlying condition leading to the sleep problem.[@R18] Such population costs have been reported for several common and important childhood health conditions such as attention-deficient/hyperactivity disorder (ADHD), overweight and autism.[@R19; @R20; @R21] If the increases in healthcare costs between those with and without sleep problems are substantial, these excess costs would provide a strong driver for implementing more systematic prevention and treatment.

The healthcare costs of sleep problems have been reported in adults.[@R22; @R23; @R24; @R25; @R26] One Australian study reported sleep problems cost \$146 million annually in 2004, with an additional \$313 million for associated conditions.[@R22] The Canadian government incurs a \$191.2 million annual healthcare burden for health consultations for patients suffering from insomnia in 2002.[@R26] However, being restricted to the costs directly associated with a diagnosed sleep problem, these adult studies do not include the costs associated with seeking a diagnosis or managing the excess comorbidities experienced by these individuals.

To date, there is very limited data on the population healthcare costs associated with childhood sleep problems in Australia and internationally. Increased costs and healthcare use have been reported in clinical groups when compared to matched controls.[@R27; @R28; @R29] However, these studies have focused on children with obstructive sleep apnoea, which is less common in children than behavioural problems.[@R1] While two other studies have reported lower healthcare costs for offering compared with not offering families a sleep intervention.[@R15] [@R17] However, these studies were restricted to infants less than 1 year of age and provided the intervention following a community-based screening procedure. Although highly cost-effective, these population-based programmes have not yet been widely implemented beyond the infant age group.

Therefore, this study aims to provide the first population healthcare costs of childhood sleep problems. This study uses data from the first two biennial waves of a large, nationally representative Australian study spanning the first 8 years of life. Drawing on the Medicare schemes that record subsidies made for visits by virtually all Australians to family doctors/specialists and their prescription medications, we aimed to determine 1 The type and costs to government of non-hospital based healthcare services in each year of life for infants and children aged 0--7 years with, compared to without, sleep problems;2 The cumulative costs according to whether sleep problems are absent, transient (ie, occur in one but not both waves) or persistent (ie, occur in both waves of data collection).

Methods {#s2}
=======

Study design and sample {#s2a}
-----------------------

Data were drawn from the first two waves of the nationally representative Longitudinal Study of Australian Children (LSAC), whose design and sample are described elsewhere.[@R30] Briefly, LSAC employed a two-stage cluster sampling design to simultaneously create two independent cohorts, birth (B cohort) and preschool (K cohort). Postcodes (except the most remote) were sampled after stratifying by state of residence and urban versus rural status to ensure proportional geographic representation. The final sampling frame then comprised all children in the relevant age ranges enrolled in the Australian Medicare database, within which 98% of all Australian children are registered, with children within each selected postcode randomly selected to populate both the B and K cohorts. Both cohorts were recruited in 2004 for wave 1 and followed up 2 years later in wave 2.

For the overall LSAC study, in the B cohort, 5107 infants aged 0--1 years participated in wave 1 (2004) and 4606 (90%) were retained as 2--3-year-old toddlers in wave 2 (2006); for the K cohort, 4983 children age 4--5 years took part in wave 1, with 4464 (90%) retained as 6--7 year olds in wave 2. [Figure 1](#BMJOPEN2012002419F1){ref-type="fig"} shows the number of children at each data collection time point, the number of children with complete sleep and Medicare data at each wave and also the final grouping within waves by exact year of age used for this study.

![Participant flow for the two LSAC cohorts.](bmjopen2012002419f01){#BMJOPEN2012002419F1}

The study was approved by the Australian Institute of Family Studies Ethics Committee, and a parent provided written informed consent to participate and to access Medicare data for every participant.

Procedures {#s2b}
----------

At both waves, data were collected by trained researchers via primary caregiver interview in the family home. Healthcare costs data were subsequently obtained by linkage with Medicare Australia data (see below). Data linkage was completed for 9375 (93%) children.

Measures {#s2c}
--------

### Child sleep problem (exposure/independent variable) {#s2c1}

Using the same question at each wave and for both cohorts, the primary caregiver reported whether or not they considered the study infant/child to have a sleep problem (no, mild, moderate or severe problem). This was dichotomised into no/mild (no sleep problem) versus moderate/severe (sleep problem) because parent perception of a more severe sleep problem is a motivator to seek help, and this dichotomisation is comparable to published cross-sectional and intervention research using the same item.[@R2] [@R5] [@R12] [@R16] Parent report was used because parent perception of a sleep problem is a key driver of help-seeking behaviour; subjective measures of sleep are more cost-effective and feasible compared to objective measures in large population-based settings[@R31]; and what constitutes a sleep problem from a research perspective remains widely debated.[@R32] Because sleep problems can be transient and thus vary from year to year, sleep problems and their associated Medicare costs were calculated for each year of life in which each child\'s sleep was reported, for example whether a wave 1 (0--1 year) infant was aged 0 or 1 year at the time of data collection.

### Healthcare system costs (dependent variable) {#s2c2}

Data from the national Medicare Benefit Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) were used to estimate the costs to the Australian government of subsidised prescription medication and healthcare attendances.[@R33] [@R34] Jointly, the MBS and PBS comprise the Australian Medicare subsidised healthcare scheme. In Australia, both Federal and State governments provide funding for public hospitals (not considered in this study). Through the MBS, the Federal government also subsidises non-hospital based medical practitioners for providing care up to a pre-determined amount, with the remainder (typically around 15%) paid by the patient. Most services covered by MBS are visits to healthcare professionals, although it also includes non-hospital diagnostic and pathology services and treatment.[@R33] [@R34] The costs of pharmaceuticals are subsidised by the PBS, in which a pre-determined list of medications and formulas are subsidised for approximately 83% of the medication costs with the remainder paid by the patient. The metrics reported in this paper represent the reimbursement for healthcare and medication costs provided by the Australian Federal Government. While recognising this is a proxy for the actual cost, we refer to this as 'costs' as we present these analyses.

MBS costs were inflated to 2012 Australian dollars (\$A1=£0.65, November 2012) using the consumer price index figures provided by the Australian Bureau of Statistics (<http://www.abs.gov.au>). Costs for each child were estimated for each year of life and also for the full 4-year period, and covered all costs incurred between 2004 and 2009 for each cohort. For the B cohort, costs were available from the child\'s birth until the child\'s fourth birthday (0--3 years of life); for the K cohort, costs were available from the child\'s fourth to eighth birthday (4--7 years of life).

### Potential confounders {#s2c3}

Family socioeconomic position (SEP),[@R35] [@R36] child gender,[@R12] [@R37] global health[@R38] and special healthcare needs (SHCN)[@R39] may all be related to both sleep problems and healthcare utilisation so were considered as potential confounding factors. Family SEP, released with the LSAC dataset for each wave, is derived from standardised scores for three variables: combined annual household income, parents' years of education and parents' occupation. Child global health was measured at each wave by parent response to "In general, how would you say your child\'s current health is?"; responses dichotomised into 'excellent/very good' versus 'good/fair/poor'. SHCN was measured at each wave using the two-item short form of the parent-reported Children with Special Health Care Needs Screener.[@R40] The measure identifies children who had a medical, behavioural or other health condition that has lasted or is expected to last at least 1 year, and who require (1) more medical care, mental health services or education services or (2) more prescription medication, as a result of their condition, than other children of the same age.

Statistical analysis {#s2d}
--------------------

Analyses were conducted using Stata V.11.0, using survey methods to weight the analyses to account for the unequal probability of participant selection into the sample, non-response and sample attrition and the multistage, clustered sampling design.[@R41] [@R42]

For aim 1, healthcare service costs were calculated for each child\'s year of life in which it was used, with all 8 years of life from year 0--7 years of age well represented. The association between sleep problems and both the number and cost of healthcare services used (MBS, PBS and combined Medicare healthcare costs) was determined for each year of life. Linear regression was used to estimate the mean differences between those with and without sleep problems, in both unadjusted analyses and analyses adjusted for the potential confounders. Because of substantial skewing in service use and costs data, the standard model-based CIs for the mean differences between groups were also validated using the bias-corrected accelerated bootstrap method.[@R43] The method of bootstrapping could not be implemented while accounting for complex survey design in Stata by first-order Taylor linearisation; however, comparison of unweighted means with and without bootstrapping revealed very small differences. Utilisation of standard linear regression techniques for highly skewed cost data is supported in large public health datasets.[@R44]

Mean between-group differences for each year of age were multiplied by Australian 2009 population statistics to estimate the population-level additional healthcare costs associated with children with reported sleep problems.[@R45]

The cumulative costs associated with persistence of sleep problems over the two 4-year spans (aim 2) were determined using unadjusted and adjusted (for the same potential confounders as above) linear regression to estimate the mean difference between those with sleep problems at neither, one or both waves within each of the B and K cohorts. Tests for trend were carried out within the regression models by including sleep problem persistence (neither, one or both waves) as a linear predictor.

Results {#s3}
=======

Sample characteristics {#s3a}
----------------------

[Figure 1](#BMJOPEN2012002419F1){ref-type="fig"} shows that sleep data and Medicare data were available for over 92% of respondents in both the cohorts at both waves having sleep data. Overall, there were 3855 children aged 0, 915 aged 1, 2886 aged 2, 1437 aged 3, 3561 aged 4, 1000 aged 5, 2707 aged 6 and 1413 aged 7 years In addition, 3998 (78.2%) children in the B cohort had complete sleep and Medicare data at both waves while 3880 (77.9%) children in the K cohort had data at both waves.

The proportion of children with moderate--severe sleep problems ranged from 17.7% at age 0 to 7% at age 7. [Table 1](#BMJOPEN2012002419TB1){ref-type="table"} shows that, for both cohorts, children with sleep problems at wave 1 were more likely to have concomitant fair/poor global health and SHCN compared to children who did not.

###### 

Sociodemographic characteristics and children\'s health

  Variable (wave 1)                  B cohort (infant)   K cohort (preschool)               
  ---------------------------------- ------------------- ---------------------- ----------- -----------
  Sample size (n)                    3960                810                    3942        619
  Child age in years (mean (SD))     0.8 (0.2)           0.8 (0.2)              4.8 (0.2)   4.8 (0.2)
  Male (%)                           50.9                54.6                   51.0        52.5
  Special healthcare needs (%)       5.3                 9.9                    12.1        21.2
  Global health poor/fair (%)        2.9                 5.5                    2.0         5.6
  Married/cohabiting (%)             90.2                90.9                   86.6        84.5
  Primary language is English (%)    78.9                78.5                   83.6        87.7
  Mother completed high school (%)   66.5                69.0                   59.2        51.9
  Socioeconomic quintile (%)                                                                
   Lowest                            14.6                12.3                   11.2        16.1
   Highest                           23.5                26.5                   22.0        16.8

Healthcare service use and costs for those with and without sleep problems (aim 1) {#s3b}
----------------------------------------------------------------------------------

In every year of age, children with sleep problems accessed more medical services per year than children without. Throughout the first 8 years of life, the family doctor was the most frequently used health service, accounting for over 60% of all healthcare costs, with specialist doctors the second most common at 10--20% (see online supplementary appendices 1 and 2). Use of both family and specialist doctors was higher for children with than without sleep problems. [Table 2](#BMJOPEN2012002419TB2){ref-type="table"} shows that mean MBS, PBS and combined Medicare costs were higher for infants and children with sleep problems compared to those without at all ages. Adjusting for sociodemographic characteristics, child global health and SHCN attenuated the estimated mean differences, which nonetheless remained statistically strong for medical service (MBS) costs for children. However, the differences in pharmaceutical (PBS) costs were small and associations therefore weak.

###### 

Association between Medicare (MBS and PBS) healthcare costs and sleep problems

  Year of life†          MBS cost (\$) per child for year by sleep problem   PBS cost (\$) per child for year by sleep problem                                                                                                      
  --------------- ------ --------------------------------------------------- --------------------------------------------------- ----------------- ----------------- --------- --------- -------- ---------------- ---------------- ------
  B cohort                                                                                                                                                                                                                          
   0              3855   647 (23)                                            562 (11)                                            84 (33 to 136)    36 (−12 to 85)    0.1       48 (12)   25 (4)   22 (−3 to 47)    14 (−12 to 40)   0.3
   1              915    470 (38)                                            375 (14)                                            94 (13 to 174)    60 (−17 to 138)   0.1       54 (31)   26 (6)   28 (−35 to 91)   23 (−41 to 87)   0.5
   2              2886   360 (24)                                            271 (7)                                             88 (42 to 135)    43 (4 to 82)      0.03      26 (6)    16 (2)   10 (−2 to 22)    4 (−7 to 16)     0.4
   3              1437   327 (32)                                            253 (10)                                            74 (9 to 140)     43 (−11 to 97)    0.1       23 (7)    18 (4)   6 (−9 to 20)     −4 (−23 to 14)   0.5
  K cohort                                                                                                                                                                                                                          
   4              3561   302 (17)                                            225 (6)                                             73 (47 to 109)    48 (20 to 73)     \<0.001   23 (3)    17 (1)   7 (0 to 14)      0.0 (−7 to 7)    0.98
   5              1000   331 (35)                                            209 (8)                                             122 (52 to 190)   94 (28 to 160)    0.005     36 (11)   17 (7)   19 (−4 to 43)    4 (−18 to 25)    0.7
   6              2707   301 (31)                                            197 (7)                                             103 (42 to 167)   53 (−1 to 106)    0.01      53 (16)   20 (2)   33 (3 to 64)     10 (−17 to 38)   0.2
   7              1413   221 (30)                                            192 (8)                                             29 (−33 to 91)    12 (−42 to 67)    0.6       29 (7)    15 (2)   15 (0 to 30)     5 (−8 to 19)     0.2

\*Adjusted for family socioeconomic position, child gender, global health and special healthcare needs.

†B cohort was of children with years of life 0--3, and K cohort was of children with years of life 4--7.

All figures are in Australian dollars (\$A1=£0.65, November 2012).

MBS, Medicare Benefit Schedule; PBS, Pharmaceutical Benefit Schedule.

There was a consistent pattern of higher combined Medicare costs (MBS + PBS) for children across all of the ages (see [table 3](#BMJOPEN2012002419TB3){ref-type="table"}). The mean excess costs of combined medical services for 1 year per child with a sleep problem ranged from \$A43 at 7 years to \$A141 at 5 years, falling to an estimated \$A18 at age 7 years to \$A98 at age 5 years once the effect of confounders was accounted for. Extrapolating to the Australian population, the additional costs to the Australian government for children experiencing sleep problems are estimated to be between \$810 335 (for all Australian 7-year olds) and \$5.2 million (for all Australian 0-year olds) per annum for each of the first 7 years of children\'s lives. For the entire population of Australian 0--7-years old children, we therefore estimate that sleep problems are associated with at least an additional \$27.5 million (95% CI \$9.2 to \$46.8 million) cost to government every year. Even after adjusting for the effect of confounders, our estimates still suggest an additional \$15.8 million (95% CI \$0.2 to \$32.9 million) cost to government.

###### 

Australian population estimates of the total Medicare costs associated with sleep problems

  Age in years   Total Medicare costs (\$) per child for year by sleep problem   Estimated prevalence (%)   Australian population (n)   Estimated excess Medicare cost (\$ millions) mean (95% CI)\*                                                    
  -------------- --------------------------------------------------------------- -------------------------- --------------------------- -------------------------------------------------------------- ------- ------ ----------- --------- ----------- --------------------
  B cohort                                                                                                                                                                                                                                              
   0             695 (28)                                                        588 (13)                   107 (46 to 167)             50 (−7 to 109)                                                 0.08    17.7   296 206     52 428    243 778     5.2 (2.4 to 8.7)
   1             523 (52)                                                        401 (17)                   121 (11 to 232)             83 (−25 to 191)                                                0.1     14.6   291 294     42 529    248 765     5.1 (0.5 to 9.8)
   2             386 (26)                                                        288 (8)                    99 (46 to 151)              48 (4 to 91)                                                   0.03    12.9   283 130     36 524    246 606     3.6 (1.7 to 5.5)
   3             351 (34)                                                        271 (12)                   78 (10 to 150)              38 (−22 to 99)                                                 0.2     11.8   279 870     33 025    246 845     2.6 (0.3 to 5.0)
  K cohort                                                                                                                                                                                                                                              
   4             326 (18)                                                        241 (7)                    84 (50 to 118)              47 (18 to 75)                                                  0.001   13.9   272 124     37 825    234 299     3.1 (1.8 to 4.4)
   5             367 (40)                                                        226 (10)                   141 (60 to 223)             98 (23 to 173)                                                 0.01    13.3   269 694     35 869    233 825     5.0 (2.1 to 8.0)
   6             354 (41)                                                        217 (8)                    137 (57 to 218)             63 (−4 to 130)                                                 0.01    5.7    268 262     15 290    252 971     2.1 (0.9 to 3.3)
   7             250 (33)                                                        207 (8)                    43 (−26 to 113)             18 (−41 to 77)                                                 0.5     7.0    269 208     18 845    250 363     0.8 (−0.5 to 2.1)
  Total                                                                                                                                                                                                        12.1   2 229 788   272 335   1 957 453   27.5 (9.2 to 46.8)

\*Adjusted for family socioeconomic position, child gender, global health and special healthcare needs.

All figures are in Australian dollars (\$A1=£0.65, November 2012).

Cumulative healthcare costs over 4 years by persistence of sleep problems (aim 2) {#s3c}
---------------------------------------------------------------------------------

In the first 4 years of life, 75.2%, 20.3% and 4.5% of B cohort children had a sleep problem at neither, one or both waves, respectively. Similarly, between 4 and 7 years of age, 84.1%, 13.0% and 2.9% of K cohort children had a sleep problem at neither, one or both waves, respectively. In both the cohorts, and for all of MBS, PBS and combined Medicare services, there was a trend whereby costs tended to be higher with increasing persistence of sleep problems ([table 4](#BMJOPEN2012002419TB4){ref-type="table"}).

###### 

Association between total Medicare costs and persistence of sleep problems

  Variable                Number of times sleep problems reported                                                                        
  ----------------------- ----------------------------------------- --------------- ------------------ -------------- ------------------ ---------
  B cohort (0--3 years)   n=3461 (75.2%)                            n=933 (20.3%)                      n=208 (4.5%)                       
   MBS                    1509 (27)                                 1670 (53)       68 (−27 to 164)    2097 (133)     270 (46 to 494)    0.007
   PBS                    75 (9)                                    138 (27)        42 (−22 to 108)    130 (38)       −7 (−100 to 86)    0.4
   Medicare total         1584 (31)                                 1807 (64)       111 (−14 to 237)   2226 (145)     263 (6 to 519)     0.01
  K cohort (4--7 years)   n=3754 (84.1%)                            n=578 (13.0%)                      n=128 (2.9%)                       
   MBS                    837 (20)                                  1054 (48)       80 (−23 to 184)    1348 (108)     264 (92 to 436)    0.002
   PBS                    69 (6)                                    141 (23)        26 (−17 to 70)     237 (98)       59 (−119 to 236)   0.3
   Medicare total         906 (23)                                  1195 (61)       106 (−17 to 231)   1585 (179)     322 (67 to 578)    \<0.001

\*Adjusted for family socioeconomic position, child gender, global health and special healthcare needs.

†Mean difference reported as the difference between each groups compared to infants/children who never had a sleep problem (reference group).

‡All figures are in Australian dollars ((\$A1=£0.65, November 2012).

Discussion {#s4}
==========

Sleep problems across the first 7 years of life were associated with an increased cost to the Australian healthcare system, estimated as an excess annual burden of \$27.5 million (95% CI \$9.2 to \$46.8 million). The extent of the cost differential for sleep problems experienced in each of the first 8 years of life (\$43 to \$141, or \$18 to \$98 per child when adjusted) is sufficient to be of potential significance to policy and healthcare costs were found to increase with greater persistence of sleep problems.

Higher healthcare costs have previously been associated with sleep problems in adult populations,[@R22; @R23; @R24; @R25] but these studies have focused only on the postdiagnosis costs of sleep problems that are frequently organic such as obstructive sleep apnoea.[@R22] In infants and children, parent concern about their child\'s sleep may be a motivator to access health services for medical advice for child sleep or associated comorbidities. Regardless of whether a sleep problem is diagnosed, the costs associated with generally seeking advice contribute to the overall costs in the Australian system and need to be considered, especially since increased costs remain even when accounting for child global health and SHCN. Further, as infants and children are more likely to have a behaviourally based sleep problem,[@R1] the costs to diagnose and treat sleep problems is likely to differ between paediatric and adult populations.

The study had a number of strengths. It is the first study to quantify excess healthcare utilisation and costs to governments incurred by infants and children with sleep problems. Our nationally representative sampling frame, large sample size and high retention rate support the generalisability of these findings and yield precise estimates of sleep problem prevalence and associated healthcare costs. Use of the same sleep measure throughout allows consistency of interpretation.

The analyses were based on actual costs recorded via the Australian government administrative data for reimbursement of healthcare benefits. These data are very accurate and are commonly used to inform Australian health policy agenda.[@R46] The excess costs associated with sleep problems, however, only reflect the services that are reimbursed by Medicare. The true costs are likely to be much higher, since Medicare excludes inpatient care, costs to educational or other systems and the additional use of family household resources such as time, effort and out of pocket expenses that could well match or exceed the costs to government reported here.

The study also has limitations. Despite the marked increase in costs for those with, compared to without, sleep problems, this study cannot infer that these costs are directly attributable to the sleep problem. Medicare data do not separate the costs of seeking and receiving help for the sleep problem itself from the costs of seeking help for other conditions or the specific type of care sought. Thus the excess costs observed may have also reflected any specific underlying conditions that may have led to the sleep disruption (eg, autism, ADHD) and/or conditions in which symptoms are exacerbated or even caused by disrupted sleep (eg, social and emotional difficulties, learning difficulties). Nonetheless, the fact that the increased costs associated with sleep problems persisted even after accounting for differences in health (overall health and SHCN) between children with and without sleep problems suggests that sleep problems themselves incur increased healthcare costs.

Another limitation is that the sleep was measured by subjective parent report rather than by more objective measures. However, parent report is the only real option for such a large population-based study, with objective measures such as overnight polysomnography unfeasible in this context and actigraphy an unreliable measure of behavioural sleep difficulties.[@R31] In addition, it reflects parent concern, which is the prime motivator for parents to seek medical advice.[@R31] [@R47] [@R48] Finally, the sleep measure could not distinguish between behavioural (eg, bedtime resistance) and organic (eg, obstructive sleep apnoea) sleep problems and therefore we cannot attribute costs to specific conditions or types of problems.

Despite being associated with a heavy financial burden to the healthcare system, parent-reported infant and child sleep problems barely register on public health agendas. Future research should focus on the effectiveness and costs of prevention and intervention programmes for childhood sleep problems, and delineating to which populations these can most efficiently be targeted. Given the costs increased as sleep problems persisted, we recommend family doctors ask about sleep and, where problems exist, assess these in detail and provide families with suitable sleep management strategies.[@R13]
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